<?xml version="1.0" encoding="UTF-8"?>
<p>To the best of our knowledge, there is no published study regarding the use of IFN β-1a in the treatment of severe COVID-19. In this randomized clinical trial, the efficacy and safety of IFN β-1a were evaluated in patients with severe COVID-19.</p>
